APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digestive System Antacids

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Digestive System Antacids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025191 pages

Choose your research edition.

Industry ResearchDigestive System Antacids Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Digestive System Antacids Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Digestive System Antacids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digestive System Antacids Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Digestive System Antacids Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Digestive System Antacids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Digestive System Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digestive System Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digestive System Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Digestive System Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Digestive System Antacids include Huasen Pharma, Takeda Pharmaceutical, Sanofi, Pfizer, CR SANJIU, GlaxoSmithKline, Bayer, AstraZeneca and Reddy'sLaboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Digestive System Antacids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digestive System Antacids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digestive System Antacids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Digestive System Antacids market size, projected growth trends, production technologies, key applications, and end-use industries.

Digestive System Antacids Segment by Company

Huasen Pharma

Takeda Pharmaceutical

Sanofi

Pfizer

CR SANJIU

GlaxoSmithKline

Bayer

AstraZeneca

Reddy'sLaboratories

Reckitt Benckiser

Procter＆Gamble

Johnson＆Johnson

CONBA

Bausch Health

Almirall

Digestive System Antacids Segment by Type

Sodium Bicarbonate Tablets

Magnesium Aluminum Carbonate Tablets

Aluminum Phosphate Gel

Compound Aluminum Hydroxide Tablets

Other

Digestive System Antacids Segment by Application

OTC Drug

Rx Drug

Digestive System Antacids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digestive System Antacids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digestive System Antacids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digestive System Antacids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Digestive System Antacids market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Digestive System Antacids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Digestive System Antacids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Digestive System Antacids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Digestive System Antacids Industry Trends Table 2. Digestive System Antacids Industry Drivers Table 3. Digestive System Antacids Industry Opportunities and Challenges Table 4. Digestive System Antacids Industry Restraints Table 5. Global Digestive System Antacids Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Digestive System Antacids Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Digestive System Antacids Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Digestive System Antacids Sales Market Share by Manufacturers Table 9. Global Digestive System Antacids Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Digestive System Antacids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Digestive System Antacids Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Digestive System Antacids Manufacturers, Product Type & Application Table 13. Global Digestive System Antacids Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Digestive System Antacids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Sodium Bicarbonate Tablets Table 17. Major Manufacturers of Magnesium Aluminum Carbonate Tablets Table 18. Major Manufacturers of Aluminum Phosphate Gel Table 19. Major Manufacturers of Compound Aluminum Hydroxide Tablets Table 20. Major Manufacturers of Other Table 21. Global Digestive System Antacids Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Digestive System Antacids Sales by Type (2021-2026) & (k units) Table 23. Global Digestive System Antacids Sales by Type (2027-2032) & (k units) Table 24. Global Digestive System Antacids Sales Market Share by Type (2021-2026) Table 25. Global Digestive System Antacids Sales Market Share by Type (2027-2032) Table 26. Global Digestive System Antacids Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Digestive System Antacids Revenue by Type (2021-2026) & (k units) Table 28. Global Digestive System Antacids Revenue by Type (2027-2032) & (k units) Table 29. Global Digestive System Antacids Revenue Market Share by Type (2021-2026) Table 30. Global Digestive System Antacids Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of OTC Drug Table 32. Major Manufacturers of Rx Drug Table 33. Global Digestive System Antacids Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Digestive System Antacids Sales by Application (2021-2026) & (k units) Table 35. Global Digestive System Antacids Sales by Application (2027-2032) & (k units) Table 36. Global Digestive System Antacids Sales Market Share by Application (2021-2026) Table 37. Global Digestive System Antacids Sales Market Share by Application (2027-2032) Table 38. Global Digestive System Antacids Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Digestive System Antacids Revenue by Application (2021-2026) & (k units) Table 40. Global Digestive System Antacids Revenue by Application (2027-2032) & (k units) Table 41. Global Digestive System Antacids Revenue Market Share by Application (2021-2026) Table 42. Global Digestive System Antacids Revenue Market Share by Application (2027-2032) Table 43. Global Digestive System Antacids Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Digestive System Antacids Sales by Region (2021-2026) & (k units) Table 45. Global Digestive System Antacids Sales Market Share by Region (2021-2026) Table 46. Global Digestive System Antacids Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Digestive System Antacids Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Digestive System Antacids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Digestive System Antacids Sales by Country (2021-2026) & (k units) Table 50. North America Digestive System Antacids Sales by Country (2027-2032) & (k units) Table 51. Europe Digestive System Antacids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Digestive System Antacids Sales by Country (2021-2026) & (k units) Table 53. Europe Digestive System Antacids Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Digestive System Antacids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Digestive System Antacids Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Digestive System Antacids Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Digestive System Antacids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Digestive System Antacids Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Digestive System Antacids Sales by Country (2027-2032) & (k units) Table 60. Global Digestive System Antacids Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Digestive System Antacids Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Digestive System Antacids Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Digestive System Antacids Revenue Market Share by Region (2021-2026) Table 64. Global Digestive System Antacids Revenue Market Share by Region (2027-2032) Table 65. Huasen Pharma Company Information Table 66. Huasen Pharma Business Overview Table 67. Huasen Pharma Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Huasen Pharma Digestive System Antacids Product Portfolio Table 69. Huasen Pharma Recent Development Table 70. Takeda Pharmaceutical Company Information Table 71. Takeda Pharmaceutical Business Overview Table 72. Takeda Pharmaceutical Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Takeda Pharmaceutical Digestive System Antacids Product Portfolio Table 74. Takeda Pharmaceutical Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sanofi Digestive System Antacids Product Portfolio Table 79. Sanofi Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Pfizer Digestive System Antacids Product Portfolio Table 84. Pfizer Recent Development Table 85. CR SANJIU Company Information Table 86. CR SANJIU Business Overview Table 87. CR SANJIU Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. CR SANJIU Digestive System Antacids Product Portfolio Table 89. CR SANJIU Recent Development Table 90. GlaxoSmithKline Company Information Table 91. GlaxoSmithKline Business Overview Table 92. GlaxoSmithKline Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. GlaxoSmithKline Digestive System Antacids Product Portfolio Table 94. GlaxoSmithKline Recent Development Table 95. Bayer Company Information Table 96. Bayer Business Overview Table 97. Bayer Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Bayer Digestive System Antacids Product Portfolio Table 99. Bayer Recent Development Table 100. AstraZeneca Company Information Table 101. AstraZeneca Business Overview Table 102. AstraZeneca Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. AstraZeneca Digestive System Antacids Product Portfolio Table 104. AstraZeneca Recent Development Table 105. Reddy'sLaboratories Company Information Table 106. Reddy'sLaboratories Business Overview Table 107. Reddy'sLaboratories Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Reddy'sLaboratories Digestive System Antacids Product Portfolio Table 109. Reddy'sLaboratories Recent Development Table 110. Reckitt Benckiser Company Information Table 111. Reckitt Benckiser Business Overview Table 112. Reckitt Benckiser Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Reckitt Benckiser Digestive System Antacids Product Portfolio Table 114. Reckitt Benckiser Recent Development Table 115. Procter＆Gamble Company Information Table 116. Procter＆Gamble Business Overview Table 117. Procter＆Gamble Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Procter＆Gamble Digestive System Antacids Product Portfolio Table 119. Procter＆Gamble Recent Development Table 120. Johnson＆Johnson Company Information Table 121. Johnson＆Johnson Business Overview Table 122. Johnson＆Johnson Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Johnson＆Johnson Digestive System Antacids Product Portfolio Table 124. Johnson＆Johnson Recent Development Table 125. CONBA Company Information Table 126. CONBA Business Overview Table 127. CONBA Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. CONBA Digestive System Antacids Product Portfolio Table 129. CONBA Recent Development Table 130. Bausch Health Company Information Table 131. Bausch Health Business Overview Table 132. Bausch Health Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Bausch Health Digestive System Antacids Product Portfolio Table 134. Bausch Health Recent Development Table 135. Almirall Company Information Table 136. Almirall Business Overview Table 137. Almirall Digestive System Antacids Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Almirall Digestive System Antacids Product Portfolio Table 139. Almirall Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Digestive System Antacids Distributors List Table 143. Digestive System Antacids Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Digestive System Antacids Product Image Figure 2. Global Digestive System Antacids Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digestive System Antacids Market Size (2021-2032) & (US$ Million) Figure 4. Global Digestive System Antacids Sales (2021-2032) & (k units) Figure 5. Global Digestive System Antacids Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Digestive System Antacids Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Sodium Bicarbonate Tablets Image Figure 9. Magnesium Aluminum Carbonate Tablets Image Figure 10. Aluminum Phosphate Gel Image Figure 11. Compound Aluminum Hydroxide Tablets Image Figure 12. Other Image Figure 13. Global Digestive System Antacids Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Digestive System Antacids Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Digestive System Antacids Sales Market Share by Type (2021-2032) Figure 16. Global Digestive System Antacids Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Digestive System Antacids Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Digestive System Antacids Revenue Market Share by Type (2021-2032) Figure 19. OTC Drug Image Figure 20. Rx Drug Image Figure 21. Global Digestive System Antacids Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Digestive System Antacids Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Digestive System Antacids Sales Market Share by Application (2021-2032) Figure 24. Global Digestive System Antacids Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Digestive System Antacids Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Digestive System Antacids Revenue Market Share by Application (2021-2032) Figure 27. North America Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Digestive System Antacids Sales Market Share by Country (2021-2032) Figure 29. U.S. Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Digestive System Antacids Sales Market Share by Country (2021-2032) Figure 34. Germany Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Digestive System Antacids Sales Market Share by Country (2021-2032) Figure 41. China Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Digestive System Antacids Sales Market Share by Country (2021-2032) Figure 49. Brazil Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Digestive System Antacids Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Digestive System Antacids Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Digestive System Antacids Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Digestive System Antacids Revenue (2021-2032) & (US$ Million) Figure 60. North America Digestive System Antacids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Digestive System Antacids Revenue (2021-2032) & (US$ Million) Figure 62. Europe Digestive System Antacids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Digestive System Antacids Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Digestive System Antacids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Digestive System Antacids Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Digestive System Antacids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Digestive System Antacids Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Digestive System Antacids Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Sodium Bicarbonate Tablets
  • Magnesium Aluminum Carbonate Tablets
  • Aluminum Phosphate Gel
  • Compound Aluminum Hydroxide Tablets
  • Other
Applications
  • OTC Drug
  • Rx Drug
Companies covered
  • Huasen Pharma
  • Takeda Pharmaceutical
  • Sanofi
  • Pfizer
  • CR SANJIU
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Reddy'sLaboratories
  • Reckitt Benckiser
  • Procter＆Gamble
  • Johnson＆Johnson
  • CONBA
  • Bausch Health
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digestive System Antacids Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digestive System Antacids Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Digestive System Antacids Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Digestive System Antacids Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Digestive System Antacids Market Dynamics
  1. 2.1 Digestive System Antacids Industry Trends
  2. 2.2 Digestive System Antacids Industry Drivers
  3. 2.3 Digestive System Antacids Industry Opportunities and Challenges
  4. 2.4 Digestive System Antacids Industry Restraints
3 Digestive System Antacids Market by Manufacturers
  1. 3.1 Global Digestive System Antacids Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Digestive System Antacids Sales by Manufacturers (2021-2026)
  3. 3.3 Global Digestive System Antacids Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Digestive System Antacids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Digestive System Antacids Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Digestive System Antacids Manufacturers, Product Type & Application
  7. 3.7 Global Digestive System Antacids Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Digestive System Antacids Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Digestive System Antacids Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Digestive System Antacids Tier 1, Tier 2, and Tier 3
4 Digestive System Antacids Market by Type
  1. 4.1 Digestive System Antacids Type Introduction
  2. 4.1.1 Sodium Bicarbonate Tablets
  3. 4.1.2 Magnesium Aluminum Carbonate Tablets
  4. 4.1.3 Aluminum Phosphate Gel
  5. 4.1.4 Compound Aluminum Hydroxide Tablets
  6. 4.1.5 Other
  7. 4.2 Global Digestive System Antacids Sales by Type
  8. 4.2.1 Global Digestive System Antacids Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Digestive System Antacids Sales by Type (2021-2032)
  10. 4.2.3 Global Digestive System Antacids Sales Market Share by Type (2021-2032)
  11. 4.3 Global Digestive System Antacids Revenue by Type
  12. 4.3.1 Global Digestive System Antacids Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Digestive System Antacids Revenue by Type (2021-2032)
  14. 4.3.3 Global Digestive System Antacids Revenue Market Share by Type (2021-2032)
5 Digestive System Antacids Market by Application
  1. 5.1 Digestive System Antacids Application Introduction
  2. 5.1.1 OTC Drug
  3. 5.1.2 Rx Drug
  4. 5.2 Global Digestive System Antacids Sales by Application
  5. 5.2.1 Global Digestive System Antacids Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Digestive System Antacids Sales by Application (2021-2032)
  7. 5.2.3 Global Digestive System Antacids Sales Market Share by Application (2021-2032)
  8. 5.3 Global Digestive System Antacids Revenue by Application
  9. 5.3.1 Global Digestive System Antacids Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Digestive System Antacids Revenue by Application (2021-2032)
  11. 5.3.3 Global Digestive System Antacids Revenue Market Share by Application (2021-2032)
6 Global Digestive System Antacids Sales by Region
  1. 6.1 Global Digestive System Antacids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digestive System Antacids Sales by Region (2021-2032)
  3. 6.2.1 Global Digestive System Antacids Sales by Region (2021-2026)
  4. 6.2.2 Global Digestive System Antacids Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digestive System Antacids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Digestive System Antacids Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Digestive System Antacids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Digestive System Antacids Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Digestive System Antacids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Digestive System Antacids Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Digestive System Antacids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Digestive System Antacids Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Digestive System Antacids Revenue by Region
  1. 7.1 Global Digestive System Antacids Revenue by Region
  2. 7.1.1 Global Digestive System Antacids Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Digestive System Antacids Revenue by Region (2021-2026)
  4. 7.1.3 Global Digestive System Antacids Revenue by Region (2027-2032)
  5. 7.1.4 Global Digestive System Antacids Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Digestive System Antacids Revenue (2021-2032)
  8. 7.2.2 North America Digestive System Antacids Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Digestive System Antacids Revenue (2021-2032)
  11. 7.3.2 Europe Digestive System Antacids Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Digestive System Antacids Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Digestive System Antacids Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Digestive System Antacids Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Digestive System Antacids Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Huasen Pharma
  2. 8.1.1 Huasen Pharma Company Information
  3. 8.1.2 Huasen Pharma Business Overview
  4. 8.1.3 Huasen Pharma Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Huasen Pharma Digestive System Antacids Product Portfolio
  6. 8.1.5 Huasen Pharma Recent Developments
  7. 8.2 Takeda Pharmaceutical
  8. 8.2.1 Takeda Pharmaceutical Company Information
  9. 8.2.2 Takeda Pharmaceutical Business Overview
  10. 8.2.3 Takeda Pharmaceutical Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceutical Digestive System Antacids Product Portfolio
  12. 8.2.5 Takeda Pharmaceutical Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Digestive System Antacids Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Digestive System Antacids Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 CR SANJIU
  26. 8.5.1 CR SANJIU Company Information
  27. 8.5.2 CR SANJIU Business Overview
  28. 8.5.3 CR SANJIU Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CR SANJIU Digestive System Antacids Product Portfolio
  30. 8.5.5 CR SANJIU Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Digestive System Antacids Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Digestive System Antacids Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Digestive System Antacids Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Reddy'sLaboratories
  50. 8.9.1 Reddy'sLaboratories Company Information
  51. 8.9.2 Reddy'sLaboratories Business Overview
  52. 8.9.3 Reddy'sLaboratories Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Reddy'sLaboratories Digestive System Antacids Product Portfolio
  54. 8.9.5 Reddy'sLaboratories Recent Developments
  55. 8.10 Reckitt Benckiser
  56. 8.10.1 Reckitt Benckiser Company Information
  57. 8.10.2 Reckitt Benckiser Business Overview
  58. 8.10.3 Reckitt Benckiser Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Reckitt Benckiser Digestive System Antacids Product Portfolio
  60. 8.10.5 Reckitt Benckiser Recent Developments
  61. 8.11 Procter＆Gamble
  62. 8.11.1 Procter＆Gamble Company Information
  63. 8.11.2 Procter＆Gamble Business Overview
  64. 8.11.3 Procter＆Gamble Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Procter＆Gamble Digestive System Antacids Product Portfolio
  66. 8.11.5 Procter＆Gamble Recent Developments
  67. 8.12 Johnson＆Johnson
  68. 8.12.1 Johnson＆Johnson Company Information
  69. 8.12.2 Johnson＆Johnson Business Overview
  70. 8.12.3 Johnson＆Johnson Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Johnson＆Johnson Digestive System Antacids Product Portfolio
  72. 8.12.5 Johnson＆Johnson Recent Developments
  73. 8.13 CONBA
  74. 8.13.1 CONBA Company Information
  75. 8.13.2 CONBA Business Overview
  76. 8.13.3 CONBA Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CONBA Digestive System Antacids Product Portfolio
  78. 8.13.5 CONBA Recent Developments
  79. 8.14 Bausch Health
  80. 8.14.1 Bausch Health Company Information
  81. 8.14.2 Bausch Health Business Overview
  82. 8.14.3 Bausch Health Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bausch Health Digestive System Antacids Product Portfolio
  84. 8.14.5 Bausch Health Recent Developments
  85. 8.15 Almirall
  86. 8.15.1 Almirall Company Information
  87. 8.15.2 Almirall Business Overview
  88. 8.15.3 Almirall Digestive System Antacids Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Almirall Digestive System Antacids Product Portfolio
  90. 8.15.5 Almirall Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Digestive System Antacids Value Chain Analysis
  2. 9.1.1 Digestive System Antacids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Digestive System Antacids Production Mode & Process
  6. 9.2 Digestive System Antacids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Digestive System Antacids Distributors
  9. 9.2.3 Digestive System Antacids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst